New treatment for disfiguring skin condition

by Claire Mooney
Researchers see the light over new treatment

Researchers from The University of Manchester and Salford Royal NHS Foundation Trust have tested a new way to treat a disfiguring skin condition.

Telangiectatases are knot-like clusters of blood vessels on the skin which can occur in 30 to 50 per cent of with systemic sclerosis, a potentially serious and incurable auto-immune condition that affects .

Telangiectases tend to occur on the face, neck and upper limbs and can cause psychological issues for patients.

Currently, doctors use to blast the telangiectases and destroy them but this treatment can be painful at the time and result in bruising afterwards so researchers have been looking for an alternative.

Salford Royal is one of only a handful of Trusts in the UK specialising in systemic sclerosis, also known as scleroderma, and Consultant Rheumatologist Ariane Herrick, also Professor of Rheumatology at The University of Manchester's Institute for Inflammation and Repair, is a leading UK expert in the condition.

As part of the Trust's and University's wide range of studies to improve care of scleroderma patients, researchers tested using intense pulsed light (IPL) instead of laser treatment. IPL is often used cosmetically for treating birthmarks and for hair removal.

Their pilot study treated 19 patients with telangiectases, using IPL on one side of the face and laser treatment on the other. They had three treatments over the course of eight weeks before the results were analysed using close-up photographs and specialist imaging.

The research showed that the effects were roughly comparable but IPL had fewer side effects.

Salford Royal Rheumatology researcher Dr Graham Dinsdale, who is also a Research Associate at the University's Institute of Inflammation and Repair, said: "While this was only a small-scale , it does suggest the potential for an alternative, less painful, treatment for telangiectases. We will continue to do all we can to find new and better treatments for patients with , which is a very serious and debilitating condition."

add to favorites email to friend print save as pdf

Related Stories

New study to develop personalised treatments for psoriasis

Nov 06, 2013

A world-leading taskforce led by The University of Manchester has begun work to create a new test to help medics work out which treatment plan is most likely to improve the disabling skin condition psoriasis, based on a patient's ...

Recommended for you

Restrictions lifted at British bird flu farm

12 hours ago

Britain on Sunday lifted all restrictions at a duck farm in northern England after last month's outbreak of H5N8 bird flu, the same strain seen in recent cases across Europe.

Recorded Ebola deaths top 7,000

Dec 20, 2014

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

Dec 20, 2014

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.